4 Segment information

4.1 Information by business segments

	Life Sciences Business		PartneringBusiness		Corporate/consolidation		Group
CHF 1,000	2013	2014	2013	2014	2013	2014	2013	2014
Sales third	223,706	236,271	164,586	163,247	–	–	388,292	399,518
Intersegment sales¹	12,776	10,721	3,318	3,604	(16,094)	(14,325)	–	–
Total sales	236,482	246,992	167,904	166,851	(16,094)	(14,325)	388,292	399,518

Operating profit	18,375	40,182	42,740	24,936	(6,315)	(7,915)	54,800	57,203

Depreciation and amortization²	(6,608)	(6,603)	(3,651)	(3,736)	–	–	(10,259)	(10,339)
Impairment losses	–	–	–	–	–	–	–	–

¹ Intersegment transactions are conducted at arm’s length.
² No significant non-cash items other than depreciation of property, plant and equipment and amortization of intangible assets were incurred.

CHF 1,000	2013	2014
Reconciliation of reportable segment sales
Total sales for reportable segments	404,386	413,843
Elimination of intersegment sales	(16,094)	(14,325)
Total consolidated sales	388,292	399,518

Reconciliation of reportable segment profit
Total operating profit for reportable segments	61,115	65,118
Unallocated costs (business development, investor relations and other corporate costs) and consolidation entries	(6,315)	(7,915)
Financial result	693	(8,059)
Total consolidated profit before taxes	55,493	49,144

4.2 Entity-wide-disclosures

Products and service

CHF 1,000	2013	2014
Products	255,769	264,936
Services	132,523	134,582

Total sales third	388,292	399,518

Sales by regions (by location of customers)

CHF 1,000	2013	2014
Switzerland	11,792	11,448
Other Europe	155,103	165,223
North America	159,122	152,837
Asia	50,969	58,185
Others	11,306	11,825

Total sales third	388,292	399,518

Non-current assets by regions (by location of assets)

	Property, plant and equipment		Intangible assets
CHF 1,000	2013	2014	2013	2014
Switzerland	10,721	9,414	46,720	81,521
Other Europe	4,884	5,942	1,419	12,946
North America	3,814	4,304	–	751
Asia	436	454	432	352

Balance at December 31	19,855	20,114	48,571	95,570